V

Viswanathan

Active Director Director DIN 08674430
DIN 08674430 First appointment Jan 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Viswanathan

Data last updated:

Viswanathan is a Director at Speciality Nectar Pharma India Private Limited (since 2020). The company operates in Trading. Speciality Nectar Pharma India Private Limited reported revenue of ₹2.67 Cr (FY 2023).

DIN 08674430
Primary Designation Director
Industry Trading
First Appointment 21 Jan 2020
Oldest Company Age 6 yrs
Largest company Speciality Nectar Pharma India Private Limited · ₹2.67 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20202020₹2.67 Cr (FY 2023)Active

Board colleagues of Viswanathan

Directorship timeline

Open interactive timeline →
Speciality Nectar Pharma India Private Limited
Premium access

Shareholding and investment profile for Viswanathan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Viswanathan

Viswanathan currently holds 1 directorship: Speciality Nectar Pharma India Private Limited (Director, since 21 Jan 2020, revenue ₹2.67 Cr (FY 2023)).

Viswanathan was first appointed on 21 Jan 2020 as Director at Speciality Nectar Pharma India Private Limited.

The current boards of Viswanathan's companies include Ramar Vijayakumar (Speciality Nectar Pharma India Private Limited), Selvarasu (Speciality Nectar Pharma India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available